The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance
Open accessAbstract
Metabolomic screening of fasting plasma from nondiabetic subjects identified α-hydroxybutyrate (α-HB) and linoleoyl-glycerophosphocholine (L-GPC) as joint markers of insulin resistance (IR) and glucose intolerance. To test the predictivity of α-HB and L-GPC for incident dysglycemia, α-HB and L-GPC measurements were obtained in two observational cohorts, comprising 1,261 nondiabetic participants from the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) study and 2,580 from the Botnia Prospective Study, with 3-year and 9.5-year follow-up data, respectively. In both cohorts, α-HB was a positive correlate and L-GPC a negative correlate of insulin sensitivity, with α-HB reciprocally related to indices of β-cell function derived from the oral glucose tolerance test (OGTT). In follow-up, α-HB was a positive predictor (adjusted odds ratios 1.25 [95% CI 1.00–1.60] and 1.26 [1.07–1.48], respectively, for each standard deviation of predictor), and L-GPC was a negative predictor (0.64 [0.48–0.85] and 0.67 [0.54–0.84]) of dysglycemia (RISC) or type 2 diabetes (Botnia), independent of familial diabetes, sex, age, BMI, and fasting glucose. Corresponding areas under the receiver operating characteristic curve were 0.791 (RISC) and 0.783 (Botnia), similar in accuracy when substituting α-HB and L-GPC with 2-h OGTT glucose concentrations. When their activity was examined, α-HB inhibited and L-GPC stimulated glucose-induced insulin release in INS-1e cells. α-HB and L-GPC are independent predictors of worsening glucose tolerance, physiologically consistent with a joint signature of IR and β-cell dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Järvinen, H., Van Haeften, T., Renn, W., & Gerich, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.295 · Cited by 1,042
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Clinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Self-citationFatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896
Cauter, E. V., Mestrez, F., Sturis, J., & Polonsky, K. S. (1992) · Diabetes · doi:10.2337/diab.41.3.368 · Cited by 890
Plasma Amino Acid Levels and Insulin Secretion in Obesity
Felig, P., Marliss, E., & Cahill, G. F. (1969) · New England Journal of Medicine · doi:10.1056/nejm196910092811503 · Cited by 812
How good a marker is insulin level for insulin resistance?
Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726
Gall, W. E., Beebe, K., Lawton, K. A., Adam, K.-P., Mitchell, M. W., Nakhle, P. J., Ryals, J. A., Milburn, M. V., Nannipieri, M., Camastra, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010883 · Cited by 698
Self-citationHanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463
Ferrannini, E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0336 · Cited by 451
Self-citationInsulin signaling meets mitochondria in metabolism
Cheng, Z., Tseng, Y., & White, M. F. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.005 · Cited by 449
Fiehn, O., Garvey, W. T., Newman, J. W., Lok, K. H., Hoppel, C. L., & Adams, S. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015234 · Cited by 421
Huffman, K. M., Shah, S. H., Stevens, R. D., Bain, J. R., Muehlbauer, M., Slentz, C. A., Tanner, C. J., Kuchibhatla, M., Houmard, J. A., Newgard, C. B., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2075 · Cited by 410
Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state
Adams, S. H. (2011) · Advances in Nutrition · doi:10.3945/an.111.000737 · Cited by 394
Groop, L., Forsblom, C., Lehtovirta, M., Tuomi, T., Karanko, S., Nissén, M., Ehrnström, B.-O., Forsén, B., Isomaa, B., Snickars, B., et al. (1996) · Diabetes · doi:10.2337/diab.45.11.1585 · Cited by 384
Self-citationMetabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Soga, T., Ohishi, T., Matsui, T., Saito, T., Matsumoto, M., Takasaki, J., Matsumoto, S.-I., Kamohara, M., Hiyama, H., Yoshida, S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.120 · Cited by 367
Kolak, M., Westerbacka, J., Velagapudi, V. R., Wågsäter, D., Yetukuri, L., Makkonen, J., Rissanen, A., Häkkinen, A.-M., Lindell, M., Bergholm, R., et al. (2007) · Diabetes · doi:10.2337/db07-0111 · Cited by 317
Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects
Mari, A., Schmitz, O., Gastaldelli, A., Oestergaard, T., Nyholm, B., & Ferrannini, E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2002 · Cited by 303
Self-citationChu, Z.-L., Jones, R. M., He, H., Carroll, C., Gutierrez, V., Lucman, A., Moloney, M., Gao, H., Mondala, H., Bagnol, D., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1608 · Cited by 294
Beta cell function and its relation to insulin action in humans: a critical appraisal
Ferrannini, E., & Mari, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1381-z · Cited by 262
Self-citationPrediction of Type 2 Diabetes Using Simple Measures of Insulin Resistance
Hanley, A. J. G., Williams, K., Gonzalez, C., D’Agostino, R. B., Wagenknecht, L. E., Stern, M. P., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.463 · Cited by 201
Insulin Resistance of Protein Metabolism in Type 2 Diabetes
Pereira, S., Marliss, E. B., Morais, J. A., Chevalier, S., & Gougeon, R. (2008) · Diabetes · doi:10.2337/db07-0887 · Cited by 197
Insulin resistance, insulin response, and obesity as indicators of metabolic risk
Ferrannini, E., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Nolan, J., Walker, M., Natali, A., & Beck-Nielsen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0334 · Cited by 193
Self-citationReport prepared on behalf of the EGIR-RISC Study Group, Hills, S. A., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Natali, A., Walker, M., & Ferrannini, E. (2004) · Diabetologia · doi:10.1007/s00125-004-1335-5 · Cited by 179
Self-citationInsulin resistance and the metabolism of branched-chain amino acids in humans
Adeva, M. M., Calviño, J., Souto, G., & Donapetry, C. (2012) · Amino Acids · doi:10.1007/s00726-011-1088-7 · Cited by 158
Yea, K., Kim, J. J., Yoon, J. H., Kwon, T., Kim, J. H., Lee, B. D., Lee, H. J., Lee, S. J., Kim, J.-I., Lee, T. G., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024869 · Cited by 156
β‐cell function assessment from modelling of oral tests: an effective approach
Mari, A., & Ferrannini, E. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00946.x · Cited by 112
Self-citationEffect of insulin on system A amino acid transport in human skeletal muscle.
Bonadonna, R. C., Saccomani, M. P., Cobelli, C., & DeFronzo, R. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116230 · Cited by 101
Lan, H., Lin, H. V., Cf, W., Wright, M. J., Xu, S. S., Kang, L., Juhl, K., Hedrick, J., & Kowalski, T. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01754.x · Cited by 93
on behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., & Mari, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2112-x · Cited by 80
Self-citationInsulin resistance of amino acid and protein metabolism in type 2 diabetes
Tessari, P., Cecchet, D., Cosma, A., Puricelli, L., Millioni, R., Vedovato, M., & Tiengo, A. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.02.009 · Cited by 72
7 Insulin action and substrate competition
Groop, L., & Ferrannini, E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80243-5 · Cited by 51
Self-citationBranching Out for Detection of Type 2 Diabetes
Shah, S. H., Svetkey, L. P., & Newgard, C. B. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.003 · Cited by 28
Insulin secretory function in Type 2 diabetes: Does it matter how you measure it?
Reaven, G. M. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00016.x · Cited by 26
Yea, K., Kim, J. J., Lim, S., Kwon, T., Park, H. S., Park, K. S., Suh, P., & Ryu, S. H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.122 · Cited by 23
Cited by
Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
Guasch-Ferré, M., Hruby, A., Toledo, E., Clish, C. B., Martínez-González, M. A., Salas-Salvadó, J., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc15-2251 · Cited by 905
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Gaggini, M., Carli, F., Rosso, C., Buzzigoli, E., Marietti, M., Della Latta, V., Ciociaro, D., Abate, M. L., Gambino, R., Cassader, M., et al. (2018) · Hepatology · doi:10.1002/hep.29465 · Cited by 465
Chambers, E. S., Byrne, C. S., Morrison, D. J., Murphy, K. G., Preston, T., Tedford, C., Garcia-Perez, I., Fountana, S., Serrano-Contreras, J. I., Holmes, E., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318424 · Cited by 443
Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids
Haeusler, R. A., Astiarraga, B., Camastra, S., Accili, D., & Ferrannini, E. (2013) · Diabetes · doi:10.2337/db13-0639 · Cited by 444
Self-citation
Metadata
- Authors
- Ferrannini, E., Natali, A., Camastra, S., Nannipieri, M., Mari, A., Adam, K.-P., Milburn, M. V., Kastenmüller, G., Adamski, J., Tuomi, T., Lyssenko, V., Groop, L., & Gall, W. E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-04-16
- Volume
- 62
- Issue
- 5
- Pages
- 1730-1737
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2099491564
- Cited by
- 349
- References
- 40
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.